Surotomycin was an investigational oral antibiotic. This antibiotic was under investigation by Merck & Co (who acquired Cubist Pharmaceuticals) for the treatment of life-threatening Diarrhea, commonly caused by the bacterium Clostridium difficile. Reference standards of Surotomycin API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Surotomycin - API Standards [catalogue_number] => PA 19 1630000 [category_ids] => ,75,76,78,70,82, [chemical_name] => [weight] => 1680.75 [form] => C77H101N17O26 [cas] => 1233389-51-9 [pslug] => 1233389-51-9-surotomycin-api-pa191630000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 19 1630000
CAS :
Molecular Formula : C77H101N17O26
Molecular Weight : 1680.75
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
